Research indicates that levels of pro-inflammatory cytokines (TNF, IL-1β, IL-6, etc.)in the brain are elevated and correlate with disease severity and disability in the serum of patients with PD [20,47,48], and their down-regulated expression can significantly inhibit the development of PD. The gene discussed is IL6; the disease is Parkinson disease.